Skip to Main Content
Contribute Try STAT+ Today

WASHINGTON — President-elect Joe Biden has already pledged to dismantle a number of Trump-era policies and regulations. Democratic advisers, however, say he’d be wise to keep one of the slapdash drug pricing reforms that Trump touted during a White House briefing Friday.

The biggest policy will tie what the U.S. pays for approximately 50 pricey drugs to what other countries pay. The proposal is ready to be implemented, but much of the implementation will still fall to Biden, who is slated to take office in two months.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.